Abstract DDT02-04: SGN-CD33A: Preclinical and phase 1 interim clinical trial results of a CD33-directed PBD dimer antibody-drug conjugate for the treatment of acute myeloid leukemia (AML)

Published 2015 View Full Article

Authors

Keywords

Journal

CANCER RESEARCH

Volume 75, Issue 15 Supplement, Pages DDT02-04-DDT02-04

Publisher

American Association for Cancer Research (AACR)

Online

2015-08-05

DOI

10.1158/1538-7445.am2015-ddt02-04

Ask authors/readers for more resources

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started

CANCER RESEARCH

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Publish scientific posters with Peeref

Ask a Question. Answer a Question.